Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) SHH

48.59

-0.08(-0.16%)

Updated at October 20 11:29AM

Currency In CNY

Valuation

Market Cap11.91B
Enterprise Value10.54B
P/E Ratio15.67
PEG Ratio-16.3
Price/Sales Ratio5.52
Price/Book Ratio3.75
Enterprise/Revenue5.01
Enterprise/EBITDA12.97

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.35
Operating Margin0.39

Management Effectiveness

Return On Assets0.18
Return On Equity0.25

Income Statement

Revenue2.81B
Revenue/Share8.87
Gross Profit2.64B
EBITDA967.64M
Net Income1.05B
Diluted EPS3.26

Balance Sheet

Total Cash3.03B
Total Cash/Share9.44
Total Debt692.66M
Total Debt/Equity0.17
Current Ratio2.94
Book Value Per Share13.09

Price History

52-Week Change23.56
52-Week High57.98
52-Week Low34.6
Moving Average 50 Days48.67
Moving Average 200 Days39.93

Statistics

Average Volume13.77M
Shares Outstanding322.32M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.87
Trailing Annual Dividend Yield3.84
Payout Ratio0.64
Last Split Factor13:10
Last Split DateApril 30, 2024